It is of note that patients with CHF and CKD have stimulation of the renin-angiotensin system and often have high levels of circulating angiotensin II, even in the presence of angiotensin-converting enzyme inhibitor therapy [14], [15]. This evidence concerns the gene AGT and congestive heart failure.